Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

Published on: December 25, 2021

Circulating tumor cells: approaches to isolation and characterization.

Min Yu¹, Shannon Stott, Mehmet Toner

¹Howard Hughes Medical Institute, Harvard Medical School, Charlestown, MA 02129, USA.

The Journal of Cell Biology

|February 9, 2011

Summary

Isolating rare circulating tumor cells (CTCs) from blood is challenging but crucial for understanding cancer metastasis and guiding treatment. Improved CTC detection offers new avenues for early cancer diagnosis and personalized medicine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial.

The Lancet. Oncology·2026

Same author

Author Correction: HER2 expression identifies dynamic functional states within circulating breast cancer cells.

Nature·2026

Same author

ATR Safeguards Epithelial-to-Mesenchymal Transition by Countering R-loops and Enabling Transcription Reprogramming.

The Journal of clinical investigation·2026

Same author

Circulating Tumor Cells Predict Response to the DLL3-Targeting Bispecific Antibody Tarlatamab.

Cancer discovery·2026

Same author

TMPO promotes cellular dissemination and metastasis in circulating tumor cells.

bioRxiv : the preprint server for biology·2026

Area of Science:

Oncology
Biotechnology
Molecular Biology

Background:

Circulating tumor cells (CTCs) are shed from primary and metastatic cancers into the bloodstream.
CTCs are rare and admixed with normal blood components, posing significant isolation and characterization challenges.
Understanding CTC biology is vital for metastasis research and noninvasive monitoring of cancer progression.

Purpose of the Study:

To highlight the technological challenges in isolating and characterizing circulating tumor cells (CTCs).
To emphasize the potential of CTCs as biomarkers for understanding metastasis and monitoring treatment response.
To underscore the need for technological advancements to enable clinical applications of CTC analysis.

Main Methods:

This abstract does not detail specific experimental methods but discusses technological challenges and potential applications.

More Related Videos

Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model

Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model

Published on: October 9, 2015

Capture and Release of Viable Circulating Tumor Cells from Blood

Capture and Release of Viable Circulating Tumor Cells from Blood

Published on: October 28, 2016

Related Experiment Videos

Last Updated: Jun 4, 2026

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

Published on: December 25, 2021

Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model

Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model

Published on: October 9, 2015

Capture and Release of Viable Circulating Tumor Cells from Blood

Capture and Release of Viable Circulating Tumor Cells from Blood

Published on: October 28, 2016

Focuses on the importance of improving technologies for CTC isolation and characterization.

Highlights the role of advanced cellular and molecular characterization of CTCs.

Main Results:

CTCs are rare and difficult to isolate, presenting a major technological hurdle.
CTCs offer critical insights into metastasis biology and tumor genotype evolution.
Enhanced CTC isolation and characterization promise significant clinical benefits.

Conclusions:

Improved CTC isolation and characterization technologies are essential for clinical advancement.
These advancements will facilitate early disease detection and biomarker discovery.
CTC analysis holds the key to personalized treatment strategies and improved patient outcomes.